Jack Ansell, MD, Chairman of Lenox Hill Hospital’s Department of Medicine has been selected to chair The National Alliance for Thrombosis and Thrombophilia (NATT) prestigious Medical and Scientific Advisory Board (MASAB) effective September 1, 2008.
The National Alliance for Thrombosis and Thrombophilia (NATT) is a nationwide community-based patient advocacy organization. NATT’s mission is to prevent, diagnose, and treat thrombosis and thrombophilia through research, education, support and advocacy. With support from the Centers for Disease Control (CDC), NATT is at the beginning of a two year project directed at educating consumers, patients and health care professionals to prevent clotting related morbidity and mortality. Annually, there are 900,000 venous thromboembolisms and 300,000 deaths in the US, many of which are preventable.
“I am looking forward to chairing MASAB to help patients and medical and scientific leaders speak with a unified voice to increase the awareness of the enormous risks of thrombosis or clotting, most of which can be avoided,” said Dr. Ansell.
NATT President, Randy Fenninger, stated that “we are fortunate to have Dr. Ansell, an internationally recognized expert in the field of hemostasis and thrombosis in this leadership position.”
Dr. Ansell is the author of more than 200 publications including, original research, reviews, editorials, chapters, and books. Dr. Ansell’s main areas of research focus on the clinical problems of thrombosis, thrombotic disorders, and anti-thrombotic therapy. He is at the cutting edge of new methods of delivering and monitoring anti-coagulants, particularly in the management of oral anti-coagulant therapy and is involved in the clinical study of new oral anti-coagulants.